ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 1572

Ultrasound Signs of Gout in a Population with Asymptomatic Hyperuricemia

Bilal Bengana1, Aicha Ladjouze2, Nabil Baramtane Raaf3, Chaffa Aimeur4, Soraya Ayoub5, Abdenour Boukabous6 and Salima Lefkir-Tafiani7, 1University Hospital of Beni Messous Algiers - Rheumatology Department, Algiers, Algeria, 2Specialized hospital establishment of Benaknoune, Rheumatology, Algiers, Algeria, 3Hospital of Bitraria, Biochemistry, El Biar, Algiers, Algeria, 4University hospital of Mustapha Bacha, Radiology, Sidi Mhamed, Algiers, Algeria, 5University hospital of Beni Messous, Internal Medicine, BeniMessous, Algiers, Algeria, 6University Hospital of Beni Messous Algiers- Rheumatology Department, Algiers, Algeria, 7University Hospital of Beni Messous Algiers - Rheumatology Department, Benimessous, Algeria

Meeting: ACR Convergence 2021

Keywords: gout, hyperuricemia, Ultrasound, Uric Acid, Urate

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Tuesday, November 9, 2021

Title: Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster II (1565–1583)

Session Type: Poster Session D

Session Time: 8:30AM-10:30AM

Background/Purpose: Hyperuricemia is a common biological abnormality, often clinically asymptomatic. However, it can announce a gout and be linked to many diseases such as metabolic syndrome, high blood pressure or kidney disease. In fact, the majority of learned societies do not recommend any urate lowering therapy (ULT) as long as the hyperuricemia remains asymptomatic. But it turns out that part of the population with asymptomatic hyperuricemia (AH) develops a gout after a few years particularly with genetic predisposition, but also on certain risk factors that need to be confirmed. By this way, musculoskeletal ultrasound (MUS) can detect “asymptomatic gout” by visualizing signs of urate deposits (UD) in subjects with AH.

Our main objective is already to estimate the prevalence of specific signs of gout in Algerian population with AH and assess the factors exposing to UD.

Methods: This is a descriptive cross-sectional study from January 2017 to February 2019, with the recruitment of subjects with AH and serum urate level > 360 µmol/l (6 mg/dl), who do not take any ULT and have not associated any chronic inflammatory rheumatism, where we performed a MUS of the knees, metatarsophalangeal joints MTP1, MTP2 and metacarpophalangeal joint MCP2 and MCP3 with the Achilles, patellar and quadricipital tendons.

Results: We retained 258 subjects with AH, 132 women and 126 men (sex ratio = 0.95), the mean age was 59 years, the mean body mass index (BMI) was 28.4 kg / m2, 42 patients were under diuretics, 37 patients reported being on low-dose of aspirin 100 mg daily. The mean rate of serum urate levels was 460 ± 6 µmol/l , the prevalence of UD found at the MUS was 22% (n = 58), among them 36 % (21/58) had a sign of the double contour DC on the MTP1 and 29% (17/58) on the knee, 7% (4/58) had tophi on the MTP1 and 3% (2/58) had urate aggregates.

The factors reported to be linked to UD in the sample were: the male gender (p = 0.0016); the high uric acid level (p= 0.0355); BMI (p = 0.0427); taking diuretics for women (p= 0.0002).

Conclusion: Through this work, it is clear that elementary ultrasound lesions related to gout disease are common in a population with AH and concerned one fifth of subjects in our study with a higher risk in men and subjects with obesity and high uric acid level, but also in women taking diuretics. These results need to be enhanced with a randomized controlled study in order to better determine the predisposing factors for gout in any subject with AH.


Disclosures: B. Bengana, None; A. Ladjouze, None; N. Raaf, None; C. Aimeur, None; S. Ayoub, None; A. Boukabous, None; S. Lefkir-Tafiani, None.

To cite this abstract in AMA style:

Bengana B, Ladjouze A, Raaf N, Aimeur C, Ayoub S, Boukabous A, Lefkir-Tafiani S. Ultrasound Signs of Gout in a Population with Asymptomatic Hyperuricemia [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/ultrasound-signs-of-gout-in-a-population-with-asymptomatic-hyperuricemia/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ultrasound-signs-of-gout-in-a-population-with-asymptomatic-hyperuricemia/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology